Join
Live feed
·
INSIDERFilingvia Quantisnow
Zynerba Pharmaceuticals Inc. logo

SEC Form 4: Anido Armando sold $21,194 worth of shares (35,453 units at $0.60) and was granted 250,000 shares, increasing direct ownership by 35% to 826,235 units (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.
ZYNE· Zynerba Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYNE (Zynerba Pharmaceuticals Inc.) and more on Quantisnow.

SEC Form 4: Anido Armando sold $21,194 worth of shares (35,453 units at $0.60) and was granted 250,000 shares, increasing direct ownership by 35% to 826,235 units (withholding tax) | Quantisnow